• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens.

作者信息

Lafeuillade A, Jolly P, Chadapaud S, Hittinger G, Lambry V, Philip G

出版信息

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):544-6. doi: 10.1097/00126334-200308010-00018.

DOI:10.1097/00126334-200308010-00018
PMID:12869846
Abstract
摘要

相似文献

1
Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens.从含司他夫定方案转换为含替诺福韦方案的患者脂质异常的演变。
J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):544-6. doi: 10.1097/00126334-200308010-00018.
2
Summaries for patients. Treatment for resistant HIV-1 infection.患者摘要。耐药性HIV-1感染的治疗。
Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I22. doi: 10.7326/0003-4819-139-5_part_1-200309020-00001.
3
[Lipid profile and body fat--significant "side effect" of antiretroviral therapy. Tenofovir: favorable profile of adverse effects].
MMW Fortschr Med. 2003 Apr 28;145 Spec No 1:83.
4
Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
J Infect. 2003 Aug;47(2):188-9. doi: 10.1016/s0163-4453(03)00059-8.
5
Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.从司他夫定转换为含替诺福韦的治疗方案后，线粒体功能、形态和代谢参数得到改善。
J Antimicrob Chemother. 2009 Jun;63(6):1244-50. doi: 10.1093/jac/dkp100. Epub 2009 Mar 25.
6
Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).当司他夫定换用替诺福韦时，外周脂肪萎缩患者皮下脂肪、血脂谱及线粒体毒性参数的改善（LIPOTEST研究）
HIV Clin Trials. 2008 Nov-Dec;9(6):407-17. doi: 10.1310/hct0906-407.
7
Renal lesions in HIV-1-positive patient treated with tenofovir.接受替诺福韦治疗的HIV-1阳性患者的肾脏病变
AIDS. 2003 Apr 11;17(6):935-7. doi: 10.1097/00002030-200304110-00026.
8
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Eur J Med Res. 2007 Feb 26;12(2):54-60.
9
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.替诺福韦酯治疗核苷类耐药HIV-1感染的随机试验。
Ann Intern Med. 2003 Sep 2;139(5 Pt 1):313-20. doi: 10.7326/0003-4819-139-5_part_1-200309020-00006.
10
Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.在感染HIV的儿童中，将司他夫定换为替诺福韦并将蛋白酶抑制剂替换为依非韦伦后血脂异常的改善情况。
Antivir Ther. 2005;10(8):917-24.

引用本文的文献

1
Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats.含替诺福韦、恩曲他滨和依非韦伦的固定剂量复方抗逆转录病毒治疗药物与高热量饮食诱导肥胖大鼠的心脏保护作用相关。
PLoS One. 2018 Dec 5;13(12):e0208537. doi: 10.1371/journal.pone.0208537. eCollection 2018.
2
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.在临床护理中，接受抗逆转录病毒治疗的大型 HIV 感染队列中，NRTIs 对血脂水平的影响。
AIDS. 2011 Jan 14;25(2):185-95. doi: 10.1097/QAD.0b013e328341f925.
3
Coronary heart disease in HIV-infected patients.
HIV感染患者的冠心病
Curr HIV/AIDS Rep. 2005 Jun;2(2):68-73. doi: 10.1007/s11904-005-0021-7.
4
Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.富马酸替诺福韦二吡呋酯：用于治疗HIV感染的综述
Drugs. 2005;65(3):413-32. doi: 10.2165/00003495-200565030-00006.